ASSURANT, INC.

(AIZ)
  Report
Delayed Nyse  -  04:00 2022-06-24 pm EDT
172.86 USD   +2.10%
06/24Piper Sandler Downgrades Assurant to Neutral From Overweight, Adjusts Price Target to $185 From $205
MT
06/08TRANSCRIPT : Assurant, Inc. Presents at William Blair’s 42nd Annual Growth Stock Conference 2022, Jun-08-2022 11:00 AM
CI
05/31Assurant to Participate in William Blair Growth Stock Conference
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Assurant, Inc. : An opportunity over the medium term?

02/01/2022 | 03:05am EDT
long trade
Target price hit
Entry price : 151.72$ | Target : 170.8$ | Stop-loss : 143.5$ | Potential : 12.58%
The decline over the past weeks has brought the price of Assurant, Inc. shares back to an important technical support level at 144.65 USD. This represents an opportunity to take advantage of these prices levels.
Investors have an opportunity to buy the stock and target the $ 170.8.
Assurant, Inc. : Assurant, Inc. : An opportunity over the medium term?
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses
  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

© MarketScreener.com 2022

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2022 10 498 M - -
Net income 2022 599 M - -
Net Debt 2022 - - -
P/E ratio 2022 15,9x
Yield 2022 1,59%
Capitalization 9 349 M 9 349 M -
Capi. / Sales 2022 0,89x
Capi. / Sales 2023 0,84x
Nbr of Employees 15 600
Free-Float 89,3%
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 172,86 $
Average target price 204,60 $
Spread / Average Target 18,4%
EPS Revisions
Managers and Directors
Keith Warner Demmings President, Chief Executive Officer & Director
Richard Steven Dziadzio Chief Financial Officer, Treasurer & Executive VP
Elaine D. Rosen Non-Executive Chairman
Joseph A. Surber Chief Technology Officer & Senior Vice President
Keith Roland Meier Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
ASSURANT, INC.10.91%9 349
CHUBB LIMITED0.63%82 871
MARSH & MCLENNAN COMPANIES-11.07%79 845
ALLIANZ SE-12.74%77 479
ZURICH INSURANCE GROUP LTD4.40%64 929
BAJAJ FINSERV LIMITED-29.40%23 550